U.S. Physical Therapy Inc.
USPH | NYSE
$84.01
+$1.56 (+1.89%)
Sep 22, 2026, 10:46 AM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Revenue | 780.99M | 671.35M | 604.8M | 553.14M | 495.02M | 422.97M |
Cost of Revenue | 623.65M | 547.42M | 483.29M | 441.12M | 377.84M | 328.52M |
Gross Profit | 157.34M | 123.92M | 121.51M | 112.02M | 117.18M | 94.45M |
Operating Income | 80.43M | 63.21M | 52.06M | 56.8M | 70.65M | 52.41M |
Interest Income | 105K | 3.94M | 3.77M | n/a | n/a | 142K |
Pretax Income | 77.81M | 60.21M | 49.38M | 55.57M | 73.2M | 65.51M |
Net Income | 15.06M | 26.46M | 14.67M | 28.27M | 27.82M | 30.56M |
Selling & General & Admin | n/a | 58.29M | n/a | 46.11M | 46.53M | 42.04M |
Research & Development | n/a | n/a | n/a | n/a | n/a | n/a |
Other Expenses | 76.91M | 2.42M | 69.45M | 9.11M | n/a | n/a |
Operating Expenses | 76.91M | 60.71M | 69.45M | 55.22M | 46.53M | 42.04M |
Interest Expense | 9.46M | 8.02M | 9.3M | 5.78M | 942K | 1.63M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 700.56M | 608.13M | 552.74M | 496.34M | 424.37M | 370.56M |
Income Tax Expense | 19.81M | 14.61M | 12.16M | 12.16M | 15.27M | 13.02M |
Shares Outstanding (Basic) | 15.18M | 15.06M | 14.19M | 12.99M | 12.9M | 12.84M |
Shares Outstanding (Diluted) | 15.18M | 15.06M | 14.19M | 12.99M | 12.9M | 12.84M |
EPS (Basic) | 1.42 | 1.84 | 1.28 | 3.34 | 4.49 | 4.09 |
EPS (Diluted) | 1.42 | 1.84 | 1.28 | 3.34 | 4.49 | 4.09 |
EBITDA | 109.66M | 86.91M | 74.37M | 76.09M | 85.73M | 77.68M |
EBIT | 87.27M | 68.22M | 58.68M | 61.35M | 74.14M | 67.15M |
Depreciation & Amortization | 22.39M | 18.68M | 15.7M | 14.74M | 11.59M | 10.53M |
Add to Watchlist
Select watchlists to add or remove USPH